Prolonged Use of Zoledronic Acid (4 Years) Did Not Improve Outcome in Multiple Myeloma Patients.
Clinical Lymphoma Myeloma and Leukemia（2017）
摘要
Although ZA did not improve OS in patients with MM; it continued to be useful to reduce skeletal events, and thus improve better quality of life for patients.
更多查看译文
关键词
Bisphosphonates,Maintenance therapy,Multiple myeloma,Skeletal events,Zoledronic acid
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要